Clinical evaluation of T3D-959 as a potential disease remedial therapeutic for the treatment of alzheimer's disease
Ended Project Grant Awarded Last action
- Award ID
- R44AG049510
- Recipient
-
T3D Therapeutics, Inc. UEI NNGUW8XDL245
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,914,894
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- North Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $100,000 | |
| Amendment | $686,939 | |
| Original award | $1,127,955 |
Quick answers
Who received award R44AG049510?
R44AG049510 was awarded to T3D Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on March 15, 2015.
How much is award R44AG049510 worth?
$1,914,894 has been obligated on R44AG049510.
Which agency awarded R44AG049510?
National Institutes of Health (Department of Health and Human Services) awarded R44AG049510, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award